|4Feb 21, 8:19 PM ET

Cook Jennifer E. 4

4 · BridgeBio Pharma, Inc. · Filed Feb 21, 2023

Insider Transaction Report

Form 4
Period: 2021-11-16
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-16+3,5767,152 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-11-163,5760 total
    Common Stock (3,576 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% vested on November 16, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION